Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cantabio Pharmaceuticals Inc.
DescriptionSmall molecule targeting beta amyloid
Molecular Target Beta amyloid
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today